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Abstract
Background: Endometrioma is a common high-recurrence gynecological disease that
affects infertility. Surgical resection using laparotomy or laparoscopy is applied as
a standard treatment. Moreover, sclerotherapy is reported to be effective as a non-
invasive method for treating endometrioma.
Objective: To evaluate whether the ethanol retention or aspiration after sclerotherapy
improve pregnancy outcome in infertile women with endometrioma.
Materials and Methods: In a retrospective study, hospital records of 43 women with
recurrent or bilateral endometrioma who had been undergone transvaginal ultrasound
sclerotherapy were reviewed. They were selected to receive either ethanol for 10 min,
ethanol injection, irrigation, and then aspiration or total retention without aspiration
based on the surgeon’s decision. The participants were followed-up for 3, 6 and 12
months for natural or artificial conception as well as for cyst recurrence.
Results:Chemical pregnancy was positive in 52% of the women in the aspiration group
and 53.8% in the retention group. Ongoing pregnancy (44% vs 46.2%, p = 0.584) and
live birth (40% vs 46.2%, p = 0.490) were reported marginally higher in the retention
group compared with the aspiration group, and the differences were not statistically
significant. Moreover, the recurrence rate were found to be 48.1% and 37.5% in the
aspiration and retention groups, respectively (p = 0.542). The cysts size in the retention
group was significantly correlated to the recurrence rate.
Conclusion: Both the aspiration and left in situ of ethanol 95% sclerotherapy have the
similar impact on the treatment of ovarian endometrioma regarding pregnancy and
recurrence rate. However, larger randomized studies with strict inclusion criteria are
needed.
Key words: Endometrioma, Ethanol, Sclerotherapy, In vitro fertilization, Pregnancy
rate.
How to cite this article: Aflatoonian A, Tabibnejad N. “Aspiration versus retention ultrasound-guided ethanol sclerotherapy for treating endometrioma:







Tel: (+98) 35 38248123
Email:
abbas-aflatoonian@ssu.ac.ir
Received 4 November 2019
Revised 2 March 2020
Accepted 11 April 2020
Production and Hosting by
Knowledge E
Aflatoonian et al. This
article is distributed under




provided that the original




International Journal of Reproductive BioMedicine Aflatoonian et al.
1. Introduction
Endometriosis is defined as the presence
of endometrial glands and stroma outside the
uterine cavity, frequently found in the ovary in
17-44% of women with endometriosis (1). Ovarian
endometrioma is an ovarian cyst which is bound
by endometrial tissue and holds menstrual debris.
Endometrioma is displayed by dysmenorrhea (2),
pelvic pain, and subfertility (3). The conventional
management of these ovarian cysts is surgery and
the most common surgical process is laparoscopic
cystectomy. Several reports have indicated that
surgical treatment have a detrimental effect on
ovarian reserve (4-6) due to the removal of healthy
tissue next to the cyst wall (7, 8), besides excessive
ovarian coagulation (5). Therefore, there are
controversies regarding the surgical management
(9-13) along with changes of attitudes toward a
less invasive approach especially in the cases
of infertility. On the other hand, medical therapy
has been widely investigated in the treatment
of ovarian endometrioma. Oral contraceptive
pills, progestins, gonadotropin-releasing hormone
agonists (14) as well as aromatase inhibitors
(15) are effective to recover symptoms, reduce
cyst size, and decrease the risk of post-surgery
occurrence (16). However, the majority of cases
show symptom reappearance by withdrawing
medical treatment (17). Alternatively, some studies
have reported the effectiveness of sclerotherapy
on the reduction of endometrioma recurrence rate
(18-20). Ethanol sclerotherapy in combination with
transvaginal ultrasound aspiration significantly
reduce one-year recurrence rate among women
with recurrence cyst (18) and could be considered
as an effective alternative to surgery in the
management of endometrioma (21). Discrepancy
in the results of the studies investigating the
effect of ethanol sclerotherapy on the recurrence
endometrioma may be due to the difference in
ethanol concentration and volume in addition
to the number of the cysts and cyst size (22).
Furthermore, it is assumed that varied treatment
time may also affect the total recovery rate of
endometrioma (21, 23).
Therefore, in this study, we aimed to extent
our previous practice (24) to compare the different
time of ethanol exposure with regard to the risk
of recurrence and reproductive outcome in ovarian
endometrioma.
2. Materials and Methods
The current study was a retrospective review
of hospital data records of 43 women referred to
the Yazd Research and Clinical Center for Infertility
between March 2011 and April 2017.
2.1. Subjects
Women with Follicle stimulating hormone
(FSH) < 10, aged > 20 but < 39 yr, postsurgical
recurrent endometrioma or bilateral endometrioma
without surgical indication were included in
this study. They had been offered transvaginal
ultrasound sclerotherapy with 95% ethanol.
The diagnosis of endometrioma was confirmed
through sonography and the result of previous
laparotomy/laparoscopy. Additionally, cysts with
features indicative of dermoid cysts, women with
ascites, an abnormal coagulation test, history of
gynecologic cancer, refusal to participation in the
study, and those who were lost to follow-up had
been excluded.
2.2. Procedure
In this retrospective study, women were
experimentally selected to receive either ethanol
for 10 min, ethanol injection, irrigation, and then
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aspiration (aspiration group) or total retention
without aspiration (retention group) based on
the surgeon decision. In the operating room,
pentazocine (Ampulla, 30 mg/ml, Tolidaru, Iran)
and pethedine (Ampulla, 50 mg/ml, Kaspian, Iran)
had been administered as analgesic agents to
them. The site had been prepped and draped in
a sterile method. Under vaginal ultrasonographic
guidance (Honda 4000, Japan), a needle (three-
way needle, Wallace, UK) was inserted into the
endometrioma and the contents were aspirated.
The cyst cavity was irrigated with a physiological
saline till the fluid was clear in color. Next, the cyst
cavity was infused with 98% ethanol for 10 min and
then removed. In women prescribed with ethanol
retention, the ethanol was left in the cyst without
aspiration. The volume of ethanol instilled was
equal to two-third of the volume aspirated from
the endometrioma and was calculated by 80%.
The drained fluid was then sent for a cytological
examination to identify any atypical cells. Cefixim
400mg/day was started as a prophylactic antibiotic
before and after sclerotherapy for 1 wk. The women
were followed up for 3, 6, and 12 months for natural
or artificial conception, as well as cyst recurrence.
Participants’ age, duration of infertility, cyst size
and recurrence rate, and the ART outcome were
compared between the groups. Recurrence was
defined as a cyst diameter of > 3 cm. While
chemical pregnancy was defined as positive
βhCG 14 days after the embryo transfer, ongoing
pregnancy was defined as existence of fetal heart
activity on ultrasound after 12 wk.
2.3. Ethical consideration
The study was approved by the Ethics
Committee of Yazd Reproductive Sciences
Institute, Shahid Sadoughi University of Medical
Sciences; IR.SSU.RSI.REC.1398.009.
2.4. Statistical analysis
Data were analyzed using the Statistical
Package for the Social Science version 20 for
Windows (SPSS Inc, Chicago. IL, USA). The
differences between continuous variables with
normal distribution were calculated using the
Student t test. The Chi-square test was used to
compare categorical variables, and p < 0.05 was
set as the level of significance for this study.
3. Results
The mean age of the patients was 31.47 ± 4.93
yr, the mean infertility duration was 7.95 ± 4.08 yr,
and the mean cyst size was 4.52 ± 1.27 cm. No
surgical complication occurred for any patient. No
atypical cell was observed in the cytology reports
of aspirated cysts fluid. The characteristics of
both aspiration and retention group are presented
in table I. Moreover, two groups were similar in
terms of age, duration of infertility, and cyst size.
Two women (7.4%) in the aspiration group and
three (18.8%) in the retention group were lost to
follow-up. Therefore, 25 women in the aspiration
and 13 in the retention groups were analyzed for
the pregnancy outcome and recurrence rate. With
regard to pregnancy outcome, 52% of the women
in the aspiration and 53.8% in the retention group
were detected with positive chemical pregnancy.
Ongoing pregnancy (44% vs 46.2%) and live
birth (40% vs 46.2%) were reported marginally
higher in the retention group compared with
the aspiration group, and the differences were
not statistically significant (Table II). Among the
13 pregnant women in the aspiration group, 6
women (46.2%) had conceived through in vitro
fertilization (IVF) and 7 women (53.8%) became
pregnant spontaneously. However, in the retention
group, 57.1% of the women achieved pregnancy
through assisted reproduction technique and
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42.9% reached spontaneous conception. The
recurrence rates were found to be 52% and 46.2%
in the aspiration and retention groups, respectively
(p = 0.500) (Table II). The cysts size in the retention
group significantly correlated to the recurrence
rate. All cysts > 5 cm showed a recurrent form and
77.8% of cysts with a diameter of ≤ 5 cm did not
recur (p = 0.021) (Figure 1).
Table I. Characteristics of aspiration versus retention groups
Variables Aspiration (n = 27) Retention (n = 16) P-value*
Age (yr) 31.70 ± 4.79 31.06 ± 5.31 0.902
Duration of infertility (yr) 8.33 ± 4.49 7.31 ± 3.30 0.371
Cyst size (cm) 4.38 ± 1.20 4.76 ± 1.38 0.870
Data are presented as Mean ± SD; *student t test
Table II. Pregnancy outcome and recurrence rate in aspiration versus retention groups
Variables Aspiration (n = 25) Retention (n = 13) P-value*
Chemical pregnancy 13 (52) 7 (53.8) 0.593
Ongoing pregnancy 11 (44) 6 (46.2) 0.584
Live birth 10 (40) 6 (46.2) 0.490
Recurrence rate 13 (52) 6 (46.2) 0.500
Data are presented as number (%); *Chi-squared test
Figure 1. Endometrioma recurrence rate with regard to cyst size: (A) Retention group; significant differences in recurrence rate
between the cyst size of > 5 cm and the cyst size of ≤ 5, p = 0.021, Chi-square test. (B) Aspiration group.
4. Discussion
In this study, we found that both aspiration
and left in situ of ethanol 95% have the same
effect on the treatment of ovarian endometrioma
in terms of pregnancy rate as well as the
recurrence rate. The preliminary treatment
approach was cyst aspiration, followed by
ethanol injection either removed after 10 min
or retention.
Ethanol sclerotherapy is a good alternative
policy to avoid detrimental effects of laparoscopic
cystectomy on ovarian function (18, 25).
Andre and colleagues et al reported a 20%
pregnancy rate after ethanol sclerotherapy of
ovarian endometrioma subsequent to ovarian
stimulation with GnRh agonist protocol (26).
In our previous clinical trial, we enrolled 40
women with recurrent endometrioma for an
IVF cycle; 20 patients randomly underwent
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ethanol sclerotherapy. The result showed no
significant differences in the implantation and
fertilization rates as well as the clinical pregnancy
rate in both groups (24). Likewise, Lee and
colleagues found similar results in terms of
implantation and clinical pregnancy rates between
three groups of patients with endometrioma
(surgical resection, aspiration with ethanol
sclerotherapy, and the group with no intervention
(27).
With regard to the effect of treatment time
on the pregnancy, in contrast to our findings,
Chang and colleagues found that the pregnancy
rate was significantly higher in patients who
received longer treatment (more than 7 min and
left ethanol in situ) than in the patients with shorter
treatment time (0-6 min) (23). However, the total
pregnancy rate after ethanol sclerotherapy in
patients undergoing IVF ranged from 20-57%, but
the result of a systematic review and meta-analysis
revealed that the pregnancy rate was similar
after endometrioma sclerotherapy compared
with patients who underwent laparoscopic
cystectomy, and also those with no intervention
(22). Another study that evaluated the effect of
ethanol sclerotherapy duration on the treatment
of ovarian endometrioma, compared the time of
sclerotherapy up to 10 min and ethanol retention.
The authors did not report pregnancy rate but
indicated that one-year recurrence rate was
significantly lower (13%) in patients treated with
in situ ethanol retention (18). Otherwise a high
cyst recurrence rate was found in both groups
with no significant difference between ethanol
washing and ethanol retention group. Also,
Noma and Yoshida reported a 9.1% recurrence
rate using the treatment with ethanol for ≥ 10
min vs. 62.5% recurrence rate with instillation
for < 10 min (28). Likewise, in the endometrioma
treatment using 95% ethanol, the recurrence
rate was found to be 13.3% in the retention
group versus 32.1% in the irrigation group
(29).
In our previous study, endometrioma was
relapsed in 20% of women after 10 min of
sclerotherapy (24). Similarly, two other studies
reported a cyst recurrence rate of 8% and 12%
in patients with 10 and 15 min of sclerotherapy
with ethanol, respectively (21, 30). Moreover,
Castellarnau and colleagues described the
recurrence rate of 22.7% in patients who
underwent ethanol sclerotherapy compared with
those who underwent simple aspiration (72.7%)
(31). It is documented that simple ultrasonography
aspiration of endometrioma lead to a high
recurrence rate by the range of 53-97.6% (31,
32). Nevertheless, when ethanol sclerotherapy
was added to the procedure, both the recurrence
rate and following infertility were decreased (20, 21,
28, 33, 34). The results of a meta-analysis revealed
that the rates of endometrioma recurrence were
0-13.3% when ethanol was left in situ and 0-
62.5% while it was used for washing up to 15
min. Therefore, the risk of cyst recurrence was
significantly lower in women who were treated
with the use of prolonged ethanol washing than
those treated with the use of short ethanol
washing (22). In contrast, another meta-analysis
stated that endometrioma aspiration followed
by sclerotherapy does not seem to significantly
reduce the likelihood of recurrence. However, it
should be noted that this review analyzed that
studies used different sclerosing agents together
with ethanol (35).
We also found that the cyst size in the ethanol
retention group has a positive correlation with the
recurrence rate. It has been shown previously that
a larger cyst diameter is significantly associated
with recurrence (31) and that women with cyst
size ≤ 5 cm experience a higher recovery rate
(23). Additionally, Andre and colleagues stated that
ovarian cysts with a mean diameter of 4.7 cm
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did not recur after aspiration (26). It is confirmed
that larger cysts have thick multiple septa and
several cavities and hold more pathologic fillings;
therefore, a larger area of endothelial lining is
involved during the manipulation of these cysts.
Mentioned features of large cysts decrease the
ethanol efficacy and lead to incomplete procedures
and higher failure rate (23).
5. Conclusion
In conclusion, our result showed that
sclerotherapy using both aspiration and left in
situ of ethanol 95% have a similar impact on the
treatment of ovarian endometrioma regarding the
pregnancy and recurrence rates. However, larger
randomized studies with strict inclusion criteria are
necessary to evaluate the effect of endometrioma
sclerotherapy on bilateral cyst and improvement
of ART outcome.
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